Home › Breast Cancer › Texas › Killeen
Breast Cancer clinical trials in Killeen, TX
4 studies for Breast Cancer are looking for participants at sites in and around Killeen (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RecruitingPhase 3
- Baylor Scott and White Medical Center, Temple · 23 mi away
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Texas Oncology Gulf Coast, Woodland · 14 mi away
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- Baylor Scott & White Medical Center, Temple · 23 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Temple · 23 mi away
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. Learn about the types, diagnosis, and treatments.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY144 studies
- Houston, TX126 studies
- Boston, MA110 studies
- Nashville, TN78 studies
- Los Angeles, CA73 studies
- Edison, NJ70 studies
- Queens, NY67 studies
- Durham, NC63 studies
- St. Louis, MO63 studies
- Chicago, IL59 studies
- Dallas, TX54 studies
- Philadelphia, PA51 studies
Other studies in Killeen
- Post-Traumatic Stress Disorder8 studies
- Heart Failure7 studies
- Bladder Cancer6 studies
- Colorectal Cancer6 studies
- Cancer (all types)5 studies
- Metastatic Cancer4 studies
- Type 2 Diabetes4 studies
- Non-Small Cell Lung Cancer4 studies
- Endometrial Cancer4 studies
- Colon Cancer4 studies
- Ovarian Cancer4 studies
- Burkitt Lymphoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.